经过先前切口术进行膜手术的八分生长期患者的晚期存活率和自我报告的生活质量
Tedy Sawma1, Hartzell V Schaff1, Arman Arghami1
1Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.
The Annals of thoracic surgery
|September 5, 2025
概括
八十多岁患者的重复门手术显示出优异的长期存活率和改善的生活质量. 年龄不是这些心脏膜重置手术的障碍,对老年患者有显著的好处.
科学领域:
- 心血管外科
- 老年心脏病学
- 胸部手术的结果
背景情况:
- 超导管技术对老年患者的传统开放心脏手术构成了挑战.
- 高风险的患有膜疾病的老年患者需要评估手术选择.
- 对于重复的心脏门手术来说,
研究的目的:
- 评估经过重复门手术的80多岁患者的晚期存活率和生活质量.
- 评估先前的胸腔切除术对心脏膜再手术的结果的影响.
- 确定晚年是否是重复门干预的禁忌.
主要方法:
- 对934名经过心脏膜重置手术的八十多岁患者的回顾性分析 (2004-2023年).
- 终点包括长期死亡率,体力活动和一般健康状况.
- 与性别和年龄相匹配的美国人口相比生存率;确定死亡率的风险因素.
主要成果:
- 术后死亡率为6%,平均存活时间为5. 6年.
- 大多数患者在手术后的整体健康和体力活动有显著改善.
- 晚期死亡的独立预测因素包括功能衰竭,心房动和慢性肺病.
结论:
- 在八十多岁的患者中重复的门手术产生了优秀的短期和长期结果.
- 可以显著改善生活质量和身体功能.
- 年龄不应妨碍八十岁以上的患者接受必要的门干预.
相关概念视频
Mitral Stenosis IV: Nursing Management
36
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
36
Cardiomyopathy VII: Pre and Post Operative Nursing Management
27
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
27
Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
Mitral Stenosis III: Medical Management
20
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
20
Mitral Stenosis I: Introduction
34
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34
Aortic Regurgitation III: Medical Management
39
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
39


